Paul Tudor Jones Nevro Corp Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Nevro Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 130,121 shares of NVRO stock, worth $745,593. This represents 0.0% of its overall portfolio holdings.
Number of Shares
130,121
Previous 130,158
0.03%
Holding current value
$745,593
Previous $726,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding NVRO
# of Institutions
145Shares Held
37.6MCall Options Held
622KPut Options Held
1.39M-
Arrow Mark Colorado Holdings LLC Denver, CO4.36MShares$25 Million0.24% of portfolio
-
Armistice Capital, LLC New York, NY3.74MShares$21.4 Million0.2% of portfolio
-
Black Rock Inc. New York, NY3.6MShares$20.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$11.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.8MShares$10.3 Million0.01% of portfolio
About NEVRO CORP
- Ticker NVRO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 35,387,800
- Market Cap $203M
- Description
- Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...